Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

PIK sold a stake in Rubetek for ₽2.5-3 billion

2/12/25 PIKK

Court disagreed with Sual's claims against Rusal's board members

2/12/25 RUAL

Novatek reports for 2024 by IFRS

2/12/25 NVTK

Rostelecom completed testing of the first Bulat base stations

2/12/25 RTKM

Negotiations on a copper JV in China are in an active phase

2/11/25 GMKN

Bank of Russia suspended the additional share issue of Rosdorbank

2/11/25 RDRB

Sberbank's NPF plans to double the amount of funds in the PDS in 2025

2/11/25 SBER

Softline has agreed on a strategic partnership with NOTA

2/11/25 SOFL

Arenadata announced three new cloud products

2/11/25 DATA

Aeroflot's passenger traffic in January 2025 increased by 2%

2/11/25 AFLT